CALC Q1 2026 Earnings Surprising Profit on a PerShare Basis Yet Shares Decline TFX Q1 2026 Earnings EPS Surprises to the Upside with 1411 Beat Stock Edges Lower MUSA Q1 2026 Earnings EPS Surges 415 Above Estimates Stock Slightly Declines Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech CRGO Q1 2026 Earnings EPS Misses Estimates by Nearly 70 No Revenue Reported Stock Slides 574 GPRK Q1 2026 Earnings Strong EPS Performance Amidst Operational Progress